UK MHRA recalls contaminated losartan, irbesartan batches.

Recalls of selected batches or losartan- and irbesartan-containing medicines have been carried out recently due to the presence of a contaminant, says the UK's MHRA. The agency added that this recall was taking place " I as the level of contamination is above the acceptable limit i ", but that patients should not stop taking their prescribed medicine without consulting their physician " I as the health risk of discontinuing the medicine is higher than the potential risk presented by the impurity i ". [Extracted from the article]